Last reviewed · How we verify
AI assisted insulin system — Competitive Intelligence Brief
marketed
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
AI assisted insulin system (AI assisted insulin system) — Shanghai Zhongshan Hospital. An artificial intelligence-assisted system that optimizes insulin dosing and delivery by analyzing real-time glucose data and patient factors to improve glycemic control.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| AI assisted insulin system TARGET | AI assisted insulin system | Shanghai Zhongshan Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- AI assisted insulin system CI watch — RSS
- AI assisted insulin system CI watch — Atom
- AI assisted insulin system CI watch — JSON
- AI assisted insulin system alone — RSS
Cite this brief
Drug Landscape (2026). AI assisted insulin system — Competitive Intelligence Brief. https://druglandscape.com/ci/ai-assisted-insulin-system. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab